Otamixaban
- Generic Name
- Otamixaban
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H26N4O4
- CAS Number
- 193153-04-7
- Unique Ingredient Identifier
- S173RED00L
- Background
Otamixaban is a novel direct Factor Xa (FXa) inhibitor. It is currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.
- Indication
Investigated for use/treatment in thrombosis.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath